Ginkgo Bioworks Holdings, Inc.
DNA- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001830214
In the last 90 days, Ginkgo Bioworks Holdings, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $359.2M in total; Viking Global Investors is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Ginkgo Bioworks Holdings, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 316 | 316 | 0 |
| Shares | 1.14B | 1.21B | +72.2M (+6.3%) |
| Value | $1.51B | $2.25B | +$735.6M (+48.6%) |
New holders (43)
Institutions that held Ginkgo Bioworks Holdings, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (43)
Institutions that held Ginkgo Bioworks Holdings, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.